» Articles » PMID: 35075370

Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis

Overview
Publisher Hindawi
Date 2022 Jan 25
PMID 35075370
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Osteosarcoma (OS) is the most primary bone malignant tumor in adolescents. Although the treatment of OS has made great progress, patients' prognosis remains poor due to tumor invasion and metastasis.

Materials And Methods: We downloaded the expression profile GSE12865 from the Gene Expression Omnibus database. We screened differential expressed genes (DEGs) by making use of the R limma software package. Based on Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and Gene Set Enrichment Analysis, we performed the function and pathway enrichment analyses. Then, we constructed a Protein-Protein Interaction network and screened hub genes through the Search Tool for the Retrieval of Interacting Genes.

Result: By analyzing the gene expression profile GSE12865, we obtained 703 OS-related DEGs, which contained 166 genes upregulated and 537 genes downregulated. The DEGs were primarily abundant in ribosome, cell adhesion molecules, ubiquitin-ubiquitin ligase activity, and p53 signaling pathway. The hub genes of OS were KDR, CDH5, CD34, CDC42, RBX1, POLR2C, PPP2CA, and RPS2 through PPI network analysis. Finally, GSEA analysis showed that cell adhesion molecules, chemokine signal pathway, transendothelial migration, and focal adhesion were associated with OS.

Conclusion: In this study, through analyzing microarray technology and bioinformatics analysis, the hub genes and pathways about OS are identified, and the new molecular mechanism of OS is clarified.

Citing Articles

Prioritizing Context-Dependent Cancer Gene Signatures in Networks.

Capobianco E, Lisse T, Rieger S Cancers (Basel). 2025; 17(1.

PMID: 39796763 PMC: 11720092. DOI: 10.3390/cancers17010136.


The role of NOP58 in prostate cancer progression through SUMOylation regulation and drug response.

Guo W, Zong S, Liu T, Chao Y, Wang K Front Pharmacol. 2024; 15:1476025.

PMID: 39494345 PMC: 11530994. DOI: 10.3389/fphar.2024.1476025.


Identification of allograft inflammatory factor-1 suppressing the progression and indicating good prognosis of osteosarcoma.

Liu W, Shi T, Zheng D, Ke G, Chen J BMC Musculoskelet Disord. 2024; 25(1):233.

PMID: 38521928 PMC: 10960474. DOI: 10.1186/s12891-024-07363-8.


Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis.

Todosenko N, Khlusov I, Yurova K, Khaziakhmatova O, Litvinova L Int J Mol Sci. 2023; 24(10).

PMID: 37240338 PMC: 10219319. DOI: 10.3390/ijms24108993.


An Intelligent Auxiliary Framework for Bone Malignant Tumor Lesion Segmentation in Medical Image Analysis.

Zhan X, Liu J, Long H, Zhu J, Tang H, Gou F Diagnostics (Basel). 2023; 13(2).

PMID: 36673032 PMC: 9858155. DOI: 10.3390/diagnostics13020223.

References
1.
Statnikov A, Tsamardinos I, Dosbayev Y, Aliferis C . GEMS: a system for automated cancer diagnosis and biomarker discovery from microarray gene expression data. Int J Med Inform. 2005; 74(7-8):491-503. DOI: 10.1016/j.ijmedinf.2005.05.002. View

2.
Maitland M, Xu C, Cheng Y, Kistner-Griffin E, Ryan K, Karrison T . Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of Pazopanib. Clin Cancer Res. 2014; 21(2):365-72. PMC: 4323272. DOI: 10.1158/1078-0432.CCR-14-1683. View

3.
Ta H, Dass C, Choong P, Dunstan D . Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009; 28(1-2):247-63. DOI: 10.1007/s10555-009-9186-7. View

4.
Wang C, Peng J, Chen X . LncRNA-CIR promotes articular cartilage degeneration in osteoarthritis by regulating autophagy. Biochem Biophys Res Commun. 2018; 505(3):692-698. DOI: 10.1016/j.bbrc.2018.09.163. View

5.
Pan X, Chen X, Tong X, Tang C, Li J . Ppp2ca knockout in mice spermatogenesis. Reproduction. 2015; 149(4):385-91. DOI: 10.1530/REP-14-0231. View